000 | 01294 a2200385 4500 | ||
---|---|---|---|
005 | 20250516072708.0 | ||
264 | 0 | _c20120604 | |
008 | 201206s 0 0 eng d | ||
022 | _a1873-4286 | ||
024 | 7 |
_a10.2174/138161212799040510 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLymperopoulos, Anastasios | |
245 | 0 | 0 |
_aGRK2 inhibition in heart failure: something old, something new. _h[electronic resource] |
260 |
_bCurrent pharmaceutical design _c2012 |
||
300 |
_a186-91 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdrenal Glands _xmetabolism |
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aG-Protein-Coupled Receptor Kinase 2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 | _aSwine |
650 | 0 | 4 | _aUp-Regulation |
700 | 1 | _aRengo, Giuseppe | |
700 | 1 | _aKoch, Walter J | |
773 | 0 |
_tCurrent pharmaceutical design _gvol. 18 _gno. 2 _gp. 186-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/138161212799040510 _zAvailable from publisher's website |
999 |
_c21446647 _d21446647 |